3637 results for «2002»
3637 results
Coronary interventions: access, devices and outcomes
10 Oct 2025 – From AICT-AsiaPCR 2025
This session delves into the latest developments in coronary interventions, highlighting advances in vascular access techniques, innovative devices, and clinical outcomes. Topics include endothelial progenitor cell dysfunction in restenosis, the efficacy of distal radial artery (DRA) puncture and sheathless catheters in underserved areas, the use of...
NSTEMI, complex ACS and anatomy
10 Oct 2025 – From AICT-AsiaPCR 2025
This session focuses on complex cases involving non-ST elevation myocardial infarction (NSTEMI), acute coronary syndromes (ACS), and challenging coronary anatomy. It presents unique clinical scenarios such as pediatric rescue PCI, management of significant distal lesions with proximal PCI, anatomical variations complicating interventions, mixed cardiovascular disease management,...
Transcatheter mitral valve-in-valve in prior degenerated mitral valve: LIVE Educational Case from National University Heart Centre - Singapore
10 Oct 2025 – From AICT-AsiaPCR 2025
This educational session offers comprehensive guidance on transcatheter mitral valve-in-valve procedures for degenerated bioprosthetic mitral valves. Key learning points include valve sizing considerations, transeptal access techniques, and procedural steps distinct from standard transcatheter aortic valve implantation (TAVI), supported by detailed imaging analysis and a live case...
STEMI, thrombus and emergencies
10 Oct 2025 – From AICT-AsiaPCR 2025
Focused on STEMI and acute thrombotic emergencies, this session presents a series of challenging cases involving heavy thrombus burden, acute total occlusions, and complex primary angioplasty scenarios. It explores innovative approaches beyond stenting, the role of drug-coated balloons in plaque erosion, and strategic decision-making in managing...
Complex coronary challenges and anomalies
10 Oct 2025 – From AICT-AsiaPCR 2025
This session explores complex coronary challenges and anatomical anomalies encountered in clinical practice. Topics include management of thrombus showers from unexpected culprits, ultra-low contrast angioplasty in mesenteric ischemia, advanced bifurcation PCI techniques with IVUS guidance, and troubleshooting difficult stent delivery scenarios in calcified lesions and challenging...
Drug-coated balloons: a PREVAIL-ing gamechanger in complex PCI
11 Oct 2025 – From AICT-AsiaPCR 2025
Focus on the evolving role of drug-coated balloons (DCB) in complex PCI, extending their use beyond traditional indications to challenging coronary lesions and high-risk patient populations. This session reviews clinical data from the SCAAR Prevail registry and discusses the evidence journey supporting broader advocacy for DCB...
Complex coronary interventions - Current day challenges and solutions
11 Oct 2025 – From AICT-AsiaPCR 2025
Addressing current challenges in complex coronary interventions, this session covers management strategies for CHIP patients, advanced techniques for highly calcified lesions, and principles for mechanical circulatory support application in high-risk PCI scenarios. It offers practical insights and case-based discussions to optimize safety and efficacy in contemporary...
Alain G. Cribier
07 Nov 2017
In 2002, Alain Cribier revolutionised the field by introducing transcatheter aortic valve implantation (TAVI) as a complementary technique to surgery. Find out more about his early life and studies.
Transcatheter aortic valve implantation (TAVI)
10 Sep 2025
Aortic stenosis (AS) is the most common valvular heart disease leading to intervention. It is characterized by progression from leaflet thickening and calcification to significant haemodynamic stenosis which results in disease-specific symptoms and physical limitations as well as poor prognosis and impaired quality of life if...
Authors :
Aortic stenosis prevalence and balloon aortic valvuloplasty
08 Nov 2017
The transformation in the field of interventional cardiology is unprecedented. Today, interventional cardiology encompasses an ever-growing list of diagnostic and therapeutic percutaneous procedures performed in the cathlab.
In remembrance of Alain Cribier
17 Feb 2024
It is with great sadness that PCR and the interventional cardiology community learnt of the death of Professor Alain Cribier, pioneer in the non-invasive treatment of valvular disease, superb doctor and professor of medicine and great humanist whose concern and care for his patients went beyond...
PCRonline announces its new Editor-in-Chief!
14 Feb 2020
Salvatore Brugaletta is an Interventional Cardiologist at the “Hospital Clínic de Barcelona”, Spain and associate professor of Medicine at the University of Barcelona. Highly skilled in Clinical Research, Medical Education and Medical Devices with strong commitment inside medical communities, he received two PhD degrees focused on interventional cardiology from Erasmus University (Rotterdam,...
Dynamx bioadaptor restores rotational motion and vessel stress reduction in new study
02 Jun 2022
30 years of primary PCI – a tale of perseverance
16 May 2023
Over the last 30 years, primary PCI (pPCI) has evolved from an experimental ‘rescue’ intervention to an essential routine procedure – performed daily in cathlabs around the world – which is responsible for saving millions of lives. However, its path to success was far from smooth.
Elixir Medical completes enrollment in BIOADAPTOR randomized controlled trial of Dynamx Coronary Bioadaptor System
15 Feb 2022
A review of the 2024 ESC Guidelines on elevated blood pressure and hypertension
13 Nov 2024
Lucas Lauder and Felix Mahfoud provide a summary of the ESC Guidelines on elevated blood pressure and hypertension presented by John William McEvoy and Rhian Touyz at ESC Congress 2024 in London.
Author
Author
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
08 Jan 2025
In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.
Author
